#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Brain abscess Ectonucleotide pyrophosphatase/phosphodiesterase 1 deficiency Arteriosclerosis Congenital generalised lipodystrophy Hypotransferrinaemia Myotonia Pulmonary hypertension Malignant peritoneal neoplasm Gastrooesophageal cancer Glioblastoma multiforme Rheumatoid arthritis Neonatal alloimmune thrombocytopenia Haemophilia B with anti factor IX Choroidal dystrophy Small intestine neuroendocrine tumour More trials…

    Learn about Rare Diseases

    Haemolytic uraemic syndrome Basal cell naevus syndrome – Basic Information Thrombotic thrombocytopenic purpura – Trials in Disease Krabbe’s disease – Life with Disease Undifferentiated sarcoma – Treatment Ewing’s sarcoma metastatic – Basic Information Activated PI3 kinase delta syndrome – Life with Disease Leiomyosarcoma metastatic – Diagnostics Myelodysplastic syndrome – Trials in Disease Marginal zone lymphoma refractory – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Vanglusagene Ensiparvovec Sebetralstat ABY-271 Giroctocogene Fitelparvovec Tumor Necrosis Factor-Alpha Siponimod Fumaric Acid Abc-15A-116 Mebendazole Gozetotide Alf-18 Izorlisib Mesilate Trometamol Methionine Cusatuzumab Mps-213 Iti-1284 Vatiquinone Selgantolimod BUDOPRUTUG Amitriptyline Ofatumumab More therapies…

    Learn about Your Condition

    Latent tuberculosis Hypocalcaemia Radius fracture Still's disease Delayed graft function Injury Portal hypertension Breast cancer stage IV Hodgkin's disease Breast cancer stage III Rosai-Dorfman syndrome Laryngeal cancer stage II Cardiogenic shock Breast conserving surgery Post-traumatic stress disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Painful Thumb Osteoarthritis: Comparing Triamcinolone Acetonide, Sodium Chloride, and Occupational Therapy for Patients with Inflammatory Thumb Joint Pain

    Recruiting

    3 1 1
    Investigated Diseases:
    • Osteoarthritis
    Investigated Drugs:
    • Triamcinolone Acetonide
    • Sodium Chloride
    Norway

  • Study of Pemigatinib and Retifanlimab for Patients with Advanced Dedifferentiated Liposarcoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Dedifferentiated liposarcoma
    • Liposarcoma
    • Liposarcoma metastatic
    Investigated Drugs:
    • Retifanlimab
    • Pemigatinib
    Denmark Norway Sweden

  • Long-Term Safety Study of LUM-201 (Ibutamoren Mesilate) in Children with Growth Hormone Deficiency

    Recruiting

    2 1 1
    Investigated Diseases:
    • Growth hormone deficiency
    Investigated Drugs:
    • Ibutamoren Mesilate
    Poland

  • Study on Sodium Oxybate for Reducing Alcohol Consumption in Patients with Alcohol Addiction

    Recruiting

    3 1 1
    Investigated Drugs:
    • Sodium Oxybate
    France Italy Poland

  • Study on the Long-term Safety and Tolerability of Azetukalner for Patients with Epilepsy, Including Focal-onset and Primary Generalized Tonic-Clonic Seizures

    Recruiting

    3 1 1
    Investigated Drugs:
    • Azetukalner
    Austria Belgium Bulgaria Croatia Czechia Finland +10

  • Study on the Safety and Effectiveness of Dupilumab for Adults and Adolescents with Eosinophilic Gastritis and Eosinophilic Duodenitis

    Recruiting

    2 1 1
    Investigated Diseases:
    • Eosinophilic gastritis
    Investigated Drugs:
    • Dupilumab
    France Italy Poland
Previous Page
1 … 536 537 538 539 540 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!